Guest LCSC Info Posted August 24, 2012 Share Posted August 24, 2012 ASCO Lung Cancer Highlights: Dr. Socinski on Maintenance Chemo, Optimal Treatment for Frail Patients August 24th, 2012 - by Dr. Jack West http://blog.lungevity.org/2012/08/24/dr ... s-1-and-2/ We’re now ready to add the podcasts from our program on ASCO 2012 Lung Cancer Highlights program, a webinar presented by GRACE and LUNGevity that featured Drs. Mark Socinski, Professor at the University of Pittsburgh, and Joel Neal, Assistant Professor from Stanford University. The first two podcasts, both including portions of Dr. Socinski’s presentation, are below. One discussed the updated results of continuation maintenance therapy with Alimta (pemetrexed) on the PARAMOUNT trial. This summary now includes data on the overall survival in that study, which demonstrated a significant benefit for the recipients of Alimta as a continuation maintenance strategy. (Click on the link above to view the video podcasts) Dr. Socinski PARAMOUNT Trial Video Podcast Dr. Socinski PARAMOUNT Trial Audio Podcast Dr. Socinski PARAMOUNT Trial Transcript Dr. Socinski PARAMOUNT Trial Figs The second podcast covered his discussion of an important presentation by Dr. Rogerio Lilenbaum that directly compared a platinum-based doublet of carboplatin/Alimta to Alimta as a single agent in patients with a performance status of 2 — somewhat frail patients who are spending half or more of their time in bed or in a chair. Dr. Lilenbaum has particular expertise in managing lung cancer in elderly and marginal performance status patients. Up to now, his work has largely illustrated that they are not one in the same: elderly patients with a good performance status have consistently done better with more aggressive doublet therapy. Should we treat frail patients differently, or will they follow the same trends as elderly more fit patients who do best with combination therapies? Below you’ll find the audio and video versions of Dr. Socinski’s coverage of the trial, along with the transcript and figures from his presentation. (Click on the link above to view the video and audio) Dr. Socinski PS2 Single Agent vs. Doublet Trial Video Podcast Dr. Socinski PS2 Single Agent vs Doublet Trial Audio Podcast Dr. Socinski Single Agent vs Doublet Trial Transcript Dr. Socinski Single Agent vs Doublet Trial Figs We’ll continue posting additional parts of this program week by week. __________ NikoleV Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.